← Latest papers
📄 medicine

Safe Placement of a Micro-Electromechanical Systems (MEMS), Levonorgestrel Releasing Contraceptive: Cadaver and Porcine Studies

Pre-clinical studies using cadaver arms and live pigs confirmed the feasibility of safely inserting a wirelessly enabled, levonorgestrel-releasing MEMS contraceptive into the upper arm, establishing specific anatomical guidelines and demonstrating normal healing without device migration over a 2-to-4-month period.

Original authors: Elizabeth Proos, Jeffrey Kalish, Brian J. Carmine, Nicolas Pacelli, Andrea Ries Thurman

Published 2026-10-23
📖 6 min read🧠 Deep dive

Original authors: Elizabeth Proos, Jeffrey Kalish, Brian J. Carmine, Nicolas Pacelli, Andrea Ries Thurman

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

For millions of people around the world, preventing an unintended pregnancy is a matter of daily planning, often relying on methods that require remembering a pill every day or visiting a clinic for an appointment. Long-acting reversible contraception offers a different path: a small device placed under the skin that works for years without daily effort. While these implants are highly effective, they come with a specific limitation: once a person decides they want to become pregnant or stop using the method, the device must be surgically removed. This requirement for a second procedure can be a barrier for some. Researchers are now developing a new kind of implant that could change this dynamic. Instead of a solid rod that must be taken out, this new device is a tiny, wireless machine capable of pausing its release of hormones and restarting them later, all without needing surgery. Before such a device can be tested in people, however, scientists must prove it can be placed safely in the human body, ensuring it sits in the right spot without harming nearby nerves or blood vessels.

To answer this question, a team of researchers conducted a series of careful studies using human cadavers and live pigs. Their goal was to map out the safest place to insert this new device into the upper arm and to see how living tissue reacts to it over time. The device itself is a micro-electromechanical system, a tiny machine designed to release a hormone called levonorgestrel for up to ten years. Because it is wireless, drug delivery may be paused without removal to allow for pregnancy and then re-started once the user desires continued contraception, in lieu of surgical removal and re-insertion of a new device. However, because the device is a different size and shape than the implants currently in use, the team needed to verify exactly where it should go. They focused on the inner upper arm, a common site for these devices, but they needed to define precise measurements to avoid the complex network of nerves and blood vessels that run through that area.

The first phase of the research involved dissecting twelve human arms from nine different donors, ranging in age from thirty-three to eighty-one years old. The team included surgeons who specialized in general and vascular anatomy, ensuring that the examination of the body's internal structures was thorough and expert. They looked for specific landmarks on the arm: the bony bump on the inside of the elbow and the groove where the arm muscles meet. By measuring distances from these points, they sought to find a "sweet spot" where the device could sit safely under the skin but far away from critical structures like the brachial artery, the median nerve, and the basilic vein. The researchers tested this location on arms from donors with different body types, including those with higher body mass and those with lower body mass, to ensure the safety guidelines would work for a wide variety of people.

The dissections revealed that a specific zone on the inner arm was indeed safe. The team determined that the ideal spot is located between eight and ten centimeters up from the elbow bone, and four to six centimeters toward the back of the arm, away from the front groove. In this area, the device sits comfortably within the layer of fat just beneath the skin. The surgeons found that even in donors with very little body fat, the major blood vessels and nerves remained deep enough that they would not be touched by the device if placed in this target zone. They also measured the exact size of the cut needed to insert the device, finding that an opening about two centimeters wide and a pocket about four millimeters deep were sufficient. These measurements provided a clear set of instructions for how a doctor should perform the insertion to keep the patient safe.

To test how the body would react to the device over time, the team moved to a second phase involving live pigs. They chose pigs because their skin and healing processes are similar enough to humans to provide a realistic preview of what might happen in a clinical setting. The researchers inserted twenty-four non-functioning versions of the device into the backs of four pigs, placing six devices in each animal. These mock devices were made from the same materials that the final product would use, including titanium and silicone, so the body's reaction would be accurate. The pigs were monitored for several months to see how the wounds healed and whether the devices moved around.

The results from the pig study were encouraging. The devices were inserted quickly, with the entire procedure taking between six and eleven minutes on average, and there was very little bleeding. Over the course of two to four months, the incisions healed completely, and the devices stayed exactly where they were placed; none of them migrated or shifted position. When the researchers removed the devices at the end of the study, they found that the tissue had formed a thin, healthy capsule around each one, which is a normal and expected reaction to a foreign object in the body. There was no sign of inflammation or sticking to the device materials, suggesting that the body tolerates the materials well.

These findings confirm that the new wireless contraceptive device can be placed safely in the upper arm without risking injury to major nerves or blood vessels, provided the insertion follows the specific measurements identified in the study. The research also demonstrates that the materials used in the device do not cause harmful reactions in living tissue and that the body heals cleanly around the implant. While this work does not yet prove the device works for contraception in humans, it establishes the necessary safety foundation. The team has now defined the exact location and technique required for insertion, paving the way for future studies that will test whether the device can effectively prevent pregnancy while offering the unique ability to pause and restart its function without surgical removal.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →